Anti-CDK1 Alexa Fluor® 488

*Sikorski K, Mehta A, Inngjerdingen M, Thakor F, Kling S, Kalina T, Nyman TA, Stensland ME, Zhou W, de Souza GA, Holden L, Stuchly J, Templin M, Lund-Johansen F: A high-throughput pipeline for validation of antibodies. Nat Methods. 2018 Nov;15 (11) :909-912., URL: https://www.ncbi.nlm.nih.gov/pubmed/30377371 , *Lukas J, Draetta G, Bartek J: Distinct forms of human CDC2 identified by novel monoclonal antibodies. Eur J Biochem. 1992 Jul 1;207 (1) :169-76., URL: https://pubmed.ncbi.nlm.nih.gov/1628647/

*Liu ZG, Zhao LN, Liu YW, Li TT, Fan DM, Chen JJ: Activation of Cdc2 contributes to apoptosis in HPV E6 expressing human keratinocytes in response to therapeutic agents. J Mol Biol. 2007 Nov 23;374 (2) :334-45., URL: https://www.ncbi.nlm.nih.gov/pubmed/17936297?ordin, *Lindqvist A, van Zon W, Karlsson Rosenthal C, Wolthuis RM: Cyclin B1-Cdk1 activation continues after entrosome separation to control mitotic progression. PLoS Biol. 2007 May;5 (5) :e123., URL: https://www.ncbi.nlm.nih.gov/pubmed/17472438?ordin, *Hochegger H, Dejsuphong D, Sonoda E, Saberi A, Rajendra E, Kirk J, Hunt T, Takeda S: An essential role for Cdk1 in S phase control is revealed via chemical genetics in vertebrate cells. J Cell Biol. 2007 Jul 16;178 (2) :257-68., URL: https://www.ncbi.nlm.nih.gov/pubmed/17635936?ordin

The antibody POH-1 specifically detects Cdk1 (p34Cdc2; an intracellular antigen) . Staining of Cdk1 reflects the proliferating potential of respective tissue.